Company news

Jiangsu Lianhuan Pharmaceutical Co., Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

联环药业关于拟签订重大合同暨关联交易事项的公告

November 18, 2025

Announcement on Completion of Change in the Equity Structure of Indirect Shareholders

November 13, 2025

Announcement on Active Pharmaceutical Ingredient Levonorgestrel Passing the World Health Organization Prequalification On-site Inspection

November 10, 2025

Indicative Announcement on Change in Equity Structure of Controlling Shareholder

November 7, 2025

Report for Q3 2025

October 24, 2025

Announcement on Adjusting Members of Special Committees

October 17, 2025

Announcement on Outline of the 2025 Semi-annual Performance Briefing

October 13, 2025

Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025

September 30, 2025

Announcement on Convening the 2025 Semi-annual Performance Briefing

September 25, 2025

Announcement on Electing Employee Representative Director

September 18, 2025

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025

September 15, 2025

Announcement on Resolutions of the 15th Extraordinary Meeting of the 9th Board of Directors

September 12, 2025

Semi-annual Assessment Report on "Corporate Value and Return Enhancement" Action Plan 2025

August 26, 2025

Announcement on the Change of Disclosure Date for the 2025 Semi-annual Report

August 25, 2025

Announcement on Receiving Results of GMP Compliance Inspection Concerning Drugs by the Wholly-owned Subsidiary

August 19, 2025

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025

August 11, 2025

Announcement on Holding Subsidiary’s Drug Passing Generic Drug Consistency Evaluation

August 4, 2025

Notice on Convening the 1st Extraordinary General Meeting in 2025

July 24, 2025

← Newer news releases